Mesothelioma: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• BAP1 4
• PD-1 6
• TP53 0
• PD-L1 4
• YAP 0
• CDKN2A 0
• CTLA-4 2
• AXL 0
• B7-H3 0
• MDM2 0
• MET 0
• PRMT5 3
• VEGF 1
• AKT 0
• BRCA1 0
• EGFR 1
• EZH2 0
• FAK 0
• HMGB1 0
• NRF2 0
• PARP 0
• STAT3 0
• STK11 0
• TROP2 0
• AMPK 0
• ARID1A 1
• BRAF 0
• BRCA2 0
• CD30 0
• CD40 0
• CDK4/6 0
• GPC3 1
• IDH 0
• IL-17 0
• IL-6 0
• JNK 0
• LAG-3 1
• mTOR 0
• MUC1 0
• NTRK 1
• PI3K 0
• STING 0

11 of 11+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NCI · R01

  Liquid multiomics for personalized systemic treatment in malignant pleural mesothelioma

  Baylor College of Medicine· Houston, United States· US$663,998 awarded in fiscal year 2026· until Jul 2031

• NIH NCI · R01

  Microbial-based cancer therapy armored with membrane-bound cytokines for targeted immune modulation and safety-controlled delivery

  University of Michigan at Ann Arbor· Ann Arbor, United States· US$669,278 awarded in fiscal year 2026· until May 2031

• NIH NCI · R37

  Proteomic determinants of response to checkpoint blockade in malignant pleural mesothelioma

  University of California Los Angeles· Los Angeles, United States· US$407,412 awarded in fiscal year 2026· until Dec 2027

• NIH NCI · R21

  Photofrin dark effects and heme oxygenase inducers as therapeutic in mesothelioma

  University of Pennsylvania· Philadelphia, United States· US$189,922 awarded in fiscal year 2026· until Dec 2026

• NIH NCI · R01

  Tuning KITv CAR T cells for the solid tumor environment

  Sloan-Kettering Inst Can Research· New York, United States· US$1,848,264 awarded in fiscal year 2026· until Jul 2029

5 of 8 running projects, newest first. Listed amounts together: US$8.0m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

• Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  NCT05245500· Bristol-Myers Squibb· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 3
• Organoids 3
• Mendelian Randomization Analysis 1
• Gene Expression Profiling 6
• Exome Sequencing 3
• Proteomics 8
• Mass Spectrometry 3
• Flow Cytometry 6
• Immunohistochemistry 26
• Xenograft Model Antitumor Assays 21
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 3
• Machine Learning 6
• Deep Learning 1
• Cohort Studies 10
• Genome-Wide Association Study 3

• Environmental asbestos exposure and lung cancer burden compared with mesothelioma in rural Türkiye: A 33-Year population-based cohort study.

  Lung Cancer, Aug 2026

• Cancer Incidence Among Swedish Seafarers Between 1985 and 2020.

  Am J Ind Med, Aug 2026

• Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort study.

  BMC Palliat Care, Jun 2026

• Clinical and prognostic factors in pleural mesothelioma: insights from a Latin American cohort.

  Clin Transl Oncol, Apr 2026

• An Evaluation of Mortality Rates and Their Determinants in a Cohort of Former Asbestos Miners in South Africa.

  Am J Ind Med, Mar 2026

• The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and Programmed Death-Ligand 1 Expression on Overall Survival in a Select Cohort From the International Association for the Study of Lung Cancer Ninth Edition Staging Database.

  J Thorac Oncol, Mar 2026

• Mortality Update of a US Cohort of Workers in Petrochemical and Refinery Operations.

  J Occup Environ Med, Mar 2026

• Spain's Pleural Cancer Mortality 1984-2023: Insights From a Delayed Asbestos Prohibition.

  Arch Bronconeumol, Mar 2026

• Projecting future mortality risk of pleural mesothelioma in Italy (2020-2034): Bayesian age-period-cohort analysis over 40 years of death registration.

  Front Public Health, Jan 2026

• Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study.

  Lung Cancer, Jul 2016

See which targets of this disease your abstract mentions, and go to the people working on them.